SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-15-005661
Filing Date
2015-03-20
Accepted
2015-03-20 16:07:06
Documents
13
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K vbiv20141231_10k.htm 10-K 1772007
2 EXHIBIT 3.2 ex3-2.htm EX-3.2 137625
3 EXHIBIT 10.33 ex10-33.htm EX-10.33 24214
4 EXHIBIT 31.1 ex31-1.htm EX-31.1 14342
5 EXHIBIT 31.2 ex31-2.htm EX-31.2 14673
6 EXHIBIT 32.1 ex32-1.htm EX-32.1 4964
7 EXHIBIT 32.2 ex32-2.htm EX-32.2 5044
  Complete submission text file 0001437749-15-005661.txt   9975996

Data Files

Seq Description Document Type Size
8 EXHIBIT 101.INS vbiv-20141231.xml EX-101.INS 1425288
9 EXHIBIT 101.SCH vbiv-20141231.xsd EX-101.SCH 67567
10 EXHIBIT 101.CAL vbiv-20141231_cal.xml EX-101.CAL 28753
11 EXHIBIT 101.DEF vbiv-20141231_def.xml EX-101.DEF 347369
12 EXHIBIT 101.LAB vbiv-20141231_lab.xml EX-101.LAB 463570
13 EXHIBIT 101.PRE vbiv-20141231_pre.xml EX-101.PRE 344124
Mailing Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142
Business Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142 6178303031
VBI VACCINES INC. (Filer) CIK: 0000704159 (see all company filings)

IRS No.: 930589534 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-18188 | Film No.: 15716378
SIC: 2836 Biological Products, (No Diagnostic Substances)